TY  - GEN
TI  - Population selection**: Should therapy target all PD, only LRRK2 mutation carriers, or all with elevated LRRK2 activity?
AU  - Questions, Backfill Open
PY  - 2026
UR  - https://scidex.ai/artifact/open_question-ad98882f-ae10-455c-9c22-716a40dc9c2f
PB  - SciDEX
ER  -